Antiperspirant in the Treatment of Residual Limp Hyperhidrosis for

Status Completed

Clinical Trial Summary

The aim of the present pilot study is to evaluate the effect of antiperspirant to treat residual limb hyperhidrosis with the emphasis on the utility of the iodine-starch test to identify the location of the sweating.

Clinical Trial Description

Many persons with lower limb amputation report that they have major problems with sweating (hyperhidrosis) on the stump in connection with prosthetic use. Despite the frequency and the negative effect of sweating for prosthetic users, there is a lack of evidence on how the sweating should be examined and treated. In the dermatological literature, the guidelines recommend the use of topical antiperspirants such as aluminum chloride as first-line treatment. No studies have previously been published evaluating the effect of antiperspirant on prosthetic users. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05501444
Study type	Interventional
Source	Sophies Minde Ortopedi
Contact
Status	Completed
Phase	N/A
Start date	August 9, 2022
Completion date	March 30, 2023

View Details

See also
Status	Clinical Trial	Phase
Enrolling by invitation	`NCT04924036` - Qbrexza Cloths for Hyperhidrosis of Amputation Sites	Phase 2
Recruiting	`NCT04178161` - Image Guided Targeted Photoablation for the Treatment of Localized Hyperhidrosis	N/A
Completed	`NCT02552199` - A Non-Interventional Study To Assess Sweating
Completed	`NCT02565732` - Safety and Efficacy of Botulinum Toxin Type A Topical Gel for Primary Axillary Hyperhidrosis	Phase 2
Recruiting	`NCT01930604` - Botulinum Toxin Treatment in Craniofacial, Inguinal, Palmar, Plantar and Truncal Hyperhidrosis	Phase 2
Completed	`NCT01811004` - Evaluation of 1440nm Laser vs. Botulinum Toxin or miraDry® Microwave For Treatment of Axillary Hyperhidrosis	N/A
Completed	`NCT01671800` - Study to Assess the Efficacy of Botulinum Toxin B (Myobloc) for the Treatment of Prosthesis-associated Sweating	Phase 1
Completed	`NCT01956591` - Long Term Results of the Use of Oxybutynin for the Treatment of Hyperhidrosis	N/A
Completed	`NCT01934153` - Characterization of Exposure From Topical Administration of [14C] Umeclidinium to Axilla or Palm of Healthy Male Subjects	Phase 1
Completed	`NCT06113978` - Thoracoscopic Sympathetic Chain Interruption for Palmar Hyperhidrosis in Patients Below 18	N/A
Not yet recruiting	`NCT05102396` - Topical Oxybutynin for Treatment of Hyperidrosis: a Local or a Systemic Effect?	Phase 2
Completed	`NCT04906655` - An Open Label Study for Palmar Hyperhydrosis	Phase 2
Completed	`NCT05247333` - Implementation of a Minor Ailment Service in Community Pharmacy Practice	N/A
Completed	`NCT02563899` - Pharmacokinetic, Safety, Tolerability, and Clinical Effect of Topical Umeclidinium in Primary Axillary Hyperhidrosis	Phase 2
Withdrawn	`NCT05546710` - miraDry Post Market Tumescent Anesthesia Study	N/A
Completed	`NCT02016885` - A Dose-Ranging Study of the Effect of Glycopyrrolate in Subjects With Axillary Hyperhidrosis	Phase 2
Completed	`NCT00168480` - A Study Using Botulinum Toxin Type A in Patients With Axillary Hyperhidrosis	Phase 4
Completed	`NCT03416348` - Hyperhidrosis, Developing a Treatment Approach Aims 1 & 2	Phase 1
Completed	`NCT02973659` - The Use of Topical Oxybutynin 10% for Treating Primary Focal Hyperhidrosis-axillary, Palmar and Plantar.	N/A
Not yet recruiting	`NCT05805696` - Treatment and Mapping of Impostor Phenomenon	N/A

Antiperspirant in the Treatment of Residual Limp Hyperhidrosis for Prosthetic Users

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms